vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and TSS, Inc. (TSSI). Click either name above to swap in a different company.
TSS, Inc. is the larger business by last-quarter revenue ($60.9M vs $44.9M, roughly 1.4× AbCellera Biologics Inc.). TSS, Inc. runs the higher net margin — 20.0% vs -19.9%, a 39.9% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 21.8%). TSS, Inc. produced more free cash flow last quarter ($15.8M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 95.8%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
ABCL vs TSSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $60.9M |
| Net Profit | $-8.9M | $12.2M |
| Gross Margin | — | 17.6% |
| Operating Margin | -63.7% | 1.5% |
| Net Margin | -19.9% | 20.0% |
| Revenue YoY | 788.4% | 21.8% |
| Net Profit YoY | 73.9% | 535.7% |
| EPS (diluted) | $-0.03 | $0.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $60.9M | ||
| Q3 25 | $9.0M | $41.9M | ||
| Q2 25 | $17.1M | $44.0M | ||
| Q1 25 | $4.2M | $99.0M | ||
| Q4 24 | $5.0M | $50.0M | ||
| Q3 24 | $6.5M | $70.1M | ||
| Q2 24 | $7.3M | $12.2M | ||
| Q1 24 | $10.0M | $15.9M |
| Q4 25 | $-8.9M | $12.2M | ||
| Q3 25 | $-57.1M | $-1.5M | ||
| Q2 25 | $-34.7M | $1.5M | ||
| Q1 25 | $-45.6M | $3.0M | ||
| Q4 24 | — | $1.9M | ||
| Q3 24 | $-51.1M | $2.6M | ||
| Q2 24 | $-36.9M | $1.4M | ||
| Q1 24 | $-40.6M | $15.0K |
| Q4 25 | — | 17.6% | ||
| Q3 25 | — | 11.1% | ||
| Q2 25 | — | 17.8% | ||
| Q1 25 | — | 9.3% | ||
| Q4 24 | — | 14.4% | ||
| Q3 24 | — | 11.3% | ||
| Q2 24 | — | 37.3% | ||
| Q1 24 | — | 17.1% |
| Q4 25 | -63.7% | 1.5% | ||
| Q3 25 | -851.8% | -2.2% | ||
| Q2 25 | -290.2% | 5.1% | ||
| Q1 25 | -1479.6% | 4.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | -1439.4% | 5.4% | ||
| Q2 24 | -1276.2% | 14.0% | ||
| Q1 24 | -551.5% | 1.6% |
| Q4 25 | -19.9% | 20.0% | ||
| Q3 25 | -637.8% | -3.6% | ||
| Q2 25 | -203.3% | 3.4% | ||
| Q1 25 | -1077.2% | 3.0% | ||
| Q4 24 | — | 3.8% | ||
| Q3 24 | -785.4% | 3.8% | ||
| Q2 24 | -504.3% | 11.5% | ||
| Q1 24 | -408.0% | 0.1% |
| Q4 25 | $-0.03 | $0.44 | ||
| Q3 25 | $-0.19 | $-0.06 | ||
| Q2 25 | $-0.12 | $0.06 | ||
| Q1 25 | $-0.15 | $0.12 | ||
| Q4 24 | — | $0.08 | ||
| Q3 24 | $-0.17 | $0.10 | ||
| Q2 24 | $-0.13 | $0.06 | ||
| Q1 24 | $-0.14 | $0.00 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $85.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $966.9M | $76.6M |
| Total Assets | $1.4B | $184.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $85.5M | ||
| Q3 25 | $83.2M | $70.7M | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | $23.2M | ||
| Q3 24 | $126.6M | $46.4M | ||
| Q2 24 | $148.3M | $8.3M | ||
| Q1 24 | $123.6M | $14.4M |
| Q4 25 | $966.9M | $76.6M | ||
| Q3 25 | $964.0M | $63.4M | ||
| Q2 25 | $1.0B | $9.5M | ||
| Q1 25 | $1.0B | $9.4M | ||
| Q4 24 | $1.1B | $7.1M | ||
| Q3 24 | $1.1B | $7.7M | ||
| Q2 24 | $1.1B | $5.2M | ||
| Q1 24 | $1.1B | $3.7M |
| Q4 25 | $1.4B | $184.9M | ||
| Q3 25 | $1.4B | $165.4M | ||
| Q2 25 | $1.4B | $139.5M | ||
| Q1 25 | $1.3B | $113.5M | ||
| Q4 24 | $1.4B | $96.6M | ||
| Q3 24 | $1.4B | $67.3M | ||
| Q2 24 | $1.4B | $28.9M | ||
| Q1 24 | $1.5B | $26.8M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $16.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $15.8M |
| FCF MarginFCF / Revenue | -99.4% | 25.9% |
| Capex IntensityCapex / Revenue | 21.9% | 0.9% |
| Cash ConversionOCF / Net Profit | — | 1.34× |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $2.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $16.3M | ||
| Q3 25 | $-52.6M | $-18.4M | ||
| Q2 25 | $-32.4M | $16.3M | ||
| Q1 25 | $-11.6M | $20.6M | ||
| Q4 24 | $-108.6M | $-21.6M | ||
| Q3 24 | $-28.9M | $38.6M | ||
| Q2 24 | $-30.0M | $-4.3M | ||
| Q1 24 | $-41.7M | $2.6M |
| Q4 25 | $-44.6M | $15.8M | ||
| Q3 25 | $-61.5M | $-24.9M | ||
| Q2 25 | $-45.8M | $5.4M | ||
| Q1 25 | $-22.2M | $5.8M | ||
| Q4 24 | $-187.0M | $-28.4M | ||
| Q3 24 | $-47.4M | $38.6M | ||
| Q2 24 | $-50.1M | $-6.0M | ||
| Q1 24 | $-65.8M | $2.6M |
| Q4 25 | -99.4% | 25.9% | ||
| Q3 25 | -687.0% | -59.3% | ||
| Q2 25 | -267.9% | 12.3% | ||
| Q1 25 | -524.0% | 5.8% | ||
| Q4 24 | -3702.8% | -56.7% | ||
| Q3 24 | -728.4% | 55.1% | ||
| Q2 24 | -683.8% | -49.4% | ||
| Q1 24 | -661.5% | 16.4% |
| Q4 25 | 21.9% | 0.9% | ||
| Q3 25 | 99.7% | 15.3% | ||
| Q2 25 | 78.2% | 24.8% | ||
| Q1 25 | 251.1% | 15.0% | ||
| Q4 24 | 1552.7% | 13.4% | ||
| Q3 24 | 284.6% | 0.1% | ||
| Q2 24 | 274.6% | 13.8% | ||
| Q1 24 | 242.5% | 0.2% |
| Q4 25 | — | 1.34× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 11.02× | ||
| Q1 25 | — | 6.93× | ||
| Q4 24 | — | -11.32× | ||
| Q3 24 | — | 14.60× | ||
| Q2 24 | — | -3.09× | ||
| Q1 24 | — | 176.40× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ABCL
Segment breakdown not available.
TSSI
| Procurement Revenues Segment | $43.2M | 71% |
| System Integration Services Segment | $14.2M | 23% |
| Facilities Segment | $3.5M | 6% |
